Search
for
Sort by
Research 181–210 of 1000+
- Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
- Alopecia and severity of COVID-19: a cross-sectional study in Peru
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Alopecia Areata after COVID-19 Vaccines
- The effect of COVID‐19 on development of hair and nail disorders: a Turkish multicenter, controlled study
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- COVID-19 patients at referral to hospital during the first peak of disease: Common clinical findings including myalgia and fatigue
- Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
- Ultrastructural evidence for anagen hair follicle infection with SARS‐CoV‐2 in early‐onset COVID‐19 effluvium
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
- Androgenetic alopecia and COVID‐19: Is there a clinical connection?
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Indirect skin sign of COVID‐19 days: Striae rubrae
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Development of Pilomatrixoma at the Vaccination Site: A Rare Complication of COVID-19 Vaccination – A Case Report
- The debut of systemic lupus erythematosus after suffering COVID-19 = Дебют системного червоного вовчака після перенесеного COVID-19
- COVID-19 Pandemic is Not Over for Survivors with Long COVID Syndrome: Evidence of a One-Year Retrospective Follow-up Study from Iran
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- Hypoxia inducible factor-1α promotes trichogenic gene expression in human dermal papilla cells
- Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia